Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pianko

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The American Journal of Gastroenterology|May 16, 2000
Retreatment of hepatitis C patients who do not respond to interferon: the search continuesS Pianko, J McHutchison
Australian and New Zealand Journal of Medicine|December 24, 1997
Whipple's disease: unusual presentationsS Pianko, C Wells
Lancet (London, England)|November 24, 1999
Chronic hepatitis B: new therapies on the horizon?S Pianko, J McHutchison
Journal of Gastroenterology and Hepatology|August 2, 2000
Treatment of hepatitis C with interferon and ribavirinS Pianko, J G McHutchison
Journal of Gastroenterology and Hepatology|August 11, 2000
Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infectionS Pianko, S Patella, W Sievert
Journal of Viral Hepatitis|November 13, 2001
Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infectionS Pianko, S Patella, G Ostapowicz, et al.
Helicobacter|February 12, 1998
Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradicationM G Korman, T D Bolin, J L Engelman, et al.
Journal of Viral Hepatitis|February 1, 2003
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis CR P Myers, K Patel, S Pianko, et al.
Nuclear Medicine Communications|July 1, 1994
The 1-month outcome of patients with a low probability Technegas ventilation/perfusion lung scanR Bellomo, R Low, S Pianko, et al.
Journal of Viral Hepatitis|April 28, 2006
Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical settingC P Desmond, S K Roberts, F Dudley, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The American Journal of Gastroenterology|May 16, 2000
Retreatment of hepatitis C patients who do not respond to interferon: the search continuesS Pianko, J McHutchison
Australian and New Zealand Journal of Medicine|December 24, 1997
Whipple's disease: unusual presentationsS Pianko, C Wells
Lancet (London, England)|November 24, 1999
Chronic hepatitis B: new therapies on the horizon?S Pianko, J McHutchison
Journal of Gastroenterology and Hepatology|August 2, 2000
Treatment of hepatitis C with interferon and ribavirinS Pianko, J G McHutchison
Journal of Gastroenterology and Hepatology|August 11, 2000
Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infectionS Pianko, S Patella, W Sievert
Journal of Viral Hepatitis|November 13, 2001
Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infectionS Pianko, S Patella, G Ostapowicz, et al.
Helicobacter|February 12, 1998
Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradicationM G Korman, T D Bolin, J L Engelman, et al.
Journal of Viral Hepatitis|February 1, 2003
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis CR P Myers, K Patel, S Pianko, et al.
Nuclear Medicine Communications|July 1, 1994
The 1-month outcome of patients with a low probability Technegas ventilation/perfusion lung scanR Bellomo, R Low, S Pianko, et al.
Journal of Viral Hepatitis|April 28, 2006
Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical settingC P Desmond, S K Roberts, F Dudley, et al.
Pageof 2